Pherecydes Pharma Overview

  • Founded
  • 2006
Founded
  • Status
  • Public
  • Employees
  • 20
Employees
  • Stock Symbol
  • ALPHE
Stock Symbol
  • Share Price
  • $10.62
  • (As of Thursday Closing)

Pherecydes Pharma General Information

Description

Pherecydes Pharma develops phage-based therapeutic solutions for the treatment of bacterial infections. It focuses on various bacterial infections, including antibiotic-resistant infections, using phages, natural predators of bacteria that have no effect on eukaryotic cells, including human cells.

Contact Information

Ownership Status
Publicly Held
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
PAR
Primary Office
  • 20 Boulevard Bénoni Goullin
  • 44200 Nantes
  • France
+33 01 00 00 00 00

Pherecydes Pharma Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pherecydes Pharma Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.62 $10.46 $9.72 - $19.74 $61.7M 5.81M 28.2K -$0.43

Pherecydes Pharma Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
Revenue 1,553 2,532 3 360
EBITDA (3,715) (2,747) (3,692) (2,167)
Net Income (2,453) (1,368) (2,855) (1,729)
Total Assets 6,844 7,837 7,044 10,383
Total Debt 1 1,342 929 90
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pherecydes Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pherecydes Pharma‘s full profile, request access.

Request a free trial

Pherecydes Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Pherecydes Pharma develops phage-based therapeutic solutions for the treatment of bacterial infections. It focuses on va
Biotechnology
Nantes, France
20 As of 2021
0000
00.00 0000-00-00
00000000 0000

00000000

smod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exerc
0000000000000
South San Francisco, CA
00 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00

0000000

it, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
0000 000000000
Cambridge, MA
00 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pherecydes Pharma Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AvidBiotics Venture Capital-Backed South San Francisco, CA 00 000.00 00000000000 000.00
0000000 0000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
00000000 Angel-Backed Boston, MA 0 00.000 0000000000 00.000
00000 Formerly VC-backed Ness Ziona, Israel 000 00000 00000000000 00000
00000 00000000000 Formerly VC-backed Cambridge, MA 00 00000 000000000 00000
You’re viewing 5 of 16 competitors. Get the full list »

Pherecydes Pharma Executive Team (7)

Name Title Board Seat Contact Info
Guy-Charles de La Horie Chief Executive Officer
Philippe Rousseau Chief Operating Officer & Chief Financial Officer
Patrick Champion-Arnaud Ph.D Chief Marketing Officer
Cindy Fevre Ph.D Chief Scientific Officer
You’re viewing 4 of 7 executive team members. Get the full list »

Pherecydes Pharma Board Members (5)

Name Representing Role Since
Claire Poulard Omnes Capital Supervisory Board Member 000 0000
Didier Hoch Self Chairman 000 0000
Franck Lescure Ph.D Auriga Partners (Paris) Supervisory Board Member 000 0000
Leila Guerlain Nicolas GO Capital (France) Supervisory Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Pherecydes Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pherecydes Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pherecydes Pharma‘s full profile, request access.

Request a free trial